Position in TEVA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,697,818
+$1,153,787 QoQ
Shares Held
89,569
-2.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Sep 30, 2021CallValue
$4,450,206
CallShares
456,900
PutValue
$3,555,100
PutShares
365,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026IMC-Chicago, LLC holds $43,160,180 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
22,162 | $13,141,622 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
508,575 | $10,558,017 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
631,290 | $6,009,880 | |
| 4 | PRGO |
PERRIGO Co plc
|
472,311 | $5,072,620 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
89,569 | $2,697,818 | |
| 6 | ZTS |
Zoetis Inc.
|
13,989 | $1,653,639 | |
| 7 | VTRS |
Viatris Inc
|
93,825 | $1,267,575 | |
| 8 | HROW |
Harrow, Inc.
|
21,789 | $768,280 |
All Filings in TEVA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,697,818 | 89,569 | Shares | Sole | 2026-05-05 | |
| 2025-06-30 | $1,544,031 | 92,126 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,105,963 | 71,956 | Shares | Sole | 2025-04-14 | |
| 2024-09-30 | $600,570 | 33,328 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,142,456 | 70,305 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $354,838 | 25,148 | Shares | Sole | 2024-04-12 | |
| 2023-09-30 | $930,790 | 91,254 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,000,962 | 132,930 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,034,163 | 229,849 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $950,988 | 104,275 | Shares | Sole | 2023-04-24 | |
| 2022-09-30 | $617,459 | 76,513 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,406,224 | 186,998 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,227,770 | 130,753 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,929,504 | 240,887 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,555,100 | 365,000 | Put | Sole | 2021-11-05 | |
| 2021-09-30 | $4,450,206 | 456,900 | Call | Sole | 2021-11-05 | |
| 2021-09-30 | $1,073,825 | 110,249 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,303,602 | 131,677 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $951,034 | 82,412 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||